Asep Medical cuts ABT, Sepset voting stakes to 45% in reorganization deal
Reuters2026/09/05 02:27- Asep Medical restructured holdings in ABT Innovations, Sepset Biosciences, cutting indirect stakes to 45% from 50.1%.
- Settlement included intercompany debt resolution, issuance of one nonvoting preferred share in each unit to preserve economics.
- Preferred shares provide quarterly profit-based entitlement, structured similar to a royalty, with priority payout on liquidation events.
- CSE will reclassify Asep Medical as an investment company under exchange policies; name, symbol, CUSIP unchanged.
- Governance rights remain, including board representation, consent rights; Asep Medical plans continued support for development and commercialization.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bitcoin ETF inflows hit $3.8B in strongest three-week stretch of 2026

The Most Critical Date for the Bullish Cryptocurrency Bill Clarity Act Has Been Set
BPPB posts 1H 2026 net profit of EUR 23.7 million
Valued at 2 trillion! Anthropic may become the largest IPO in history, roadshow starts in October, listing before the midterm elections in November
According to sources familiar with the matter, Anthropic is expected to begin its IPO roadshow as early as mid-October and complete its listing just a few days before the U.S. midterm elections in November.
